Target intelligence / Profile preview

von Willebrand factor A domain containing 3B (VWA3B)

Target
VWA3B
Molecular classification
Other (contains a von Willebrand factor A domain, but is *not* a receptor, enzyme, transporter, or ion channel), Intracellular protein, Member of the superfamily of VWA domain-containing proteins
01

Overview

The von Willebrand factor A domain containing 3B protein (VWA3B) is an intracellular protein featuring a VWA domain—a structural motif classically found in proteins with a role in cell adhesion and the assembly of multiprotein complexes[4]. Unlike the plasma/extracellular von Willebrand factor itself, VWA3B is localized intracellularly and contributes to diverse processes including transcriptional regulation, DNA repair, ribosomal transport, membrane trafficking, and proteasome function. Mutations in VWA3B are associated with autosomal recessive spinocerebellar ataxia type 22 (SCAR22), a neurodegenerative disorder marked by motor coordination deficits[2]. Multiple transcript variants exist, reflecting plausible functional diversity in human tissues. VWA3B is not currently recognized as a pharmacological receptor, enzyme, or transporter, nor are there approved drugs targeting it directly.

Other names
SCAR22DKFZp686F2227MGC26733VWA domain-containing protein 3Bvon Willebrand factor A domain-containing protein 3BVWA3B
02

Mechanism of action

None known for drugs targeting this molecule

03

Biological functions

TranscriptionDNA repairRibosomal transportMembrane transportProteasome complex assembly
04

Disease associations

Neurodegenerative disease: mutations in VWA3B are associated with autosomal recessive spinocerebellar ataxia type 22 (SCAR22)Other: Genetic variation may relate to adverse drug reactions per population pharmacogenomics

Beyond the preview

Go deeper on von Willebrand factor A domain containing 3B (VWA3B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on von Willebrand factor A domain containing 3B (VWA3B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call